KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMY) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to $384.0 million.

  • Bristol Myers Squibb's Tax Provisions rose 28787.88% to $384.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.3 billion, marking a year-over-year increase of 31010.83%. This contributed to the annual value of $2.3 billion for FY2025, which is 31010.83% up from last year.
  • Latest data reveals that Bristol Myers Squibb reported Tax Provisions of $384.0 million as of Q4 2025, which was up 28787.88% from $919.0 million recorded in Q3 2025.
  • Bristol Myers Squibb's 5-year Tax Provisions high stood at $919.0 million for Q3 2025, and its period low was -$514.0 million during Q4 2021.
  • In the last 5 years, Bristol Myers Squibb's Tax Provisions had a median value of $432.0 million in 2022 and averaged $283.9 million.
  • Its Tax Provisions has fluctuated over the past 5 years, first plummeted by 14120.98% in 2023, then surged by 28787.88% in 2025.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Tax Provisions stood at -$514.0 million in 2021, then skyrocketed by 67.7% to -$166.0 million in 2022, then skyrocketed by 46.99% to -$88.0 million in 2023, then surged by 212.5% to $99.0 million in 2024, then skyrocketed by 287.88% to $384.0 million in 2025.
  • Its last three reported values are $384.0 million in Q4 2025, $919.0 million for Q3 2025, and $460.0 million during Q2 2025.